medigraphic.com
ISSN 0210-5187 (Electronic)

2003, Number 2

<< Back Next >>

Med Cutan Iber Lat Am 2003; 31 (2)

A Case of Lichen Myxedematosus Breast Carcinoma

Mansinho H, Cunha HM, Morgado AM, Jerónimo J, Xavier AT, Espirito SJ

Language: Portugués
References: 17
Page: 110-112
PDF size: 199.33 Kb.


ABSTRACT

Lichen myxedematosus (LM) is an idiopathic cutaneous mucinosis of unknown ethiology.
In 1953, Montgomery and Underwood described 4 clinical variants: a generalized variant, also denominated scleromyxedema, a papular one, a localized or generalized lichenoid form with plaques and a urticariform with plaques variant.
According to a more recent review 2 clinicopathological variants are described: a papular and scleroderma-like generalized variant and a localized variant.
Here we report a case of a patient with breast carcinoma and mucinosis. An atypical LM variant was diagnosed. The cutaneous lesions, the mucinous material deposition and fibroblasts in upper dermis, the absence of monoclonal paraproteinaemia and clinical hypothyroidism made the diagnosis possible.


REFERENCES

  1. Dinneen AM, Dicken ChH. Scleromyxedema. J. Am Acad Dermatol 1995; 33:37-43.

  2. Montgomery H, Underwood LJ. Lichen myxedematous (differentiation from cutaneous myxedemas or mucoid states). J. Invest Dermatol 1953;20:213-36.

  3. Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J. Am Acad Dermatol 2001;44:273-281.

  4. Farmer RF, Hambrick GW, Shulman LE. Papular Mucinosis. A clinicopathology Study of four Patients. Arch Dermatol 1982;118:9-13.

  5. Fleichmajer R. Scleredema and Papular Mucinosis in Cutaneous Manifestations of Multisystem Diseases.

  6. Csorgo BZ, Hurz S, Foldes M, Korom I et al. Scleromyxedema. J. Am Acad Dermatol 1999;40:343-6.

  7. Gabriel SE, Perry HO, Oleson GB, Bowles CA. Scleromyxedema: a scleroderma-like disorder with systemic manifestations. Medicine 1988;67:58-65.

  8. Rothe MJ, Rivas R, Gould E, Kerdel FA. Sceromyxedema and severe myositis. Int J Dermatol 1989;28:657-60.

  9. Verity MA, Toop J, McAdam LP, et al. Scleromyxedema myopathy: Histochemical and electron microscopic observations. Am J Clin Pathol 1978;69:446-51.

  10. Harvey JM, Zilko PJ, Cheah PS, et al. Scleromyxedema and inflammatory myopathy: a clinicopathologic study of three patients. Aust N Z J Med 1986;16:329-35.

  11. Helfrich DJ, Walker ER, Martinez AJ, et al Scleromyxedema myopathy: case report and review of the literature. Arthritis Rheum 1988;31:1437-41.

  12. MacAdam LP, Pearson CM, Pitts WH, et al. Papular mucinosis with myopathy, arthritis, and eosinophilia: a histopathologic study. Arthritis Rheum 1977;20:989-96.

  13. Webster GF, Matsuola LY, Burchmore D. The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis). J Am Acad Dermatol 1993;28:105-8.

  14. Danby FW, Danby CWE, Pruzansky W. Papular mucinosis with IgG(κ) M component. Can Med Assoc J. 1976;114:920-2.

  15. McCarthy JT, Osserman E, Lombardo PC, et al. An abnormal serum globulin in lichen myxedematosus. Arch Dermatol 1964;89:446-50.

  16. Lo PY, Tzung TY. Lichen myxedematosus in a patient with hepatocellular carcinoma. Bri J Dermatol 2000;143:452-3.

  17. Alberts AS, Schulz EJ, Falkson G, Simon IW, Coccia-Portugal MA. Normalization of skin appearance in a patient with scleromyxedema after intensive chemotherapy for Hodgkins disease. Dermatologica 1989;178:221-4.




2020     |     www.medigraphic.com